» Articles » PMID: 29367558

in the Heart of Understanding Cardiac Diseases: Modeling Channelopathies and Cardiomyopathies in the Fruitfly

Overview
Date 2018 Jan 26
PMID 29367558
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases and, among them, channelopathies and cardiomyopathies are a major cause of death worldwide. The molecular and genetic defects underlying these cardiac disorders are complex, leading to a large range of structural and functional heart phenotypes. Identification of molecular and functional mechanisms disrupted by mutations causing channelopathies and cardiomyopathies is essential to understanding the link between an altered gene and clinical phenotype. The development of animal models has been proven to be efficient for functional studies in channelopathies and cardiomyopathies. In particular, the model has been largely applied for deciphering the molecular and cellular pathways affected in these inherited cardiac disorders and for identifying their genetic modifiers. Here we review the utility and the main contributions of the fruitfly models for the better understanding of channelopathies and cardiomyopathies. We also discuss the investigated pathological mechanisms and the discoveries of evolutionarily conserved pathways which reinforce the value of in modeling human cardiac diseases.

Citing Articles

Animal models in biomedical research: Relevance of .

Obafemi O, Ayeleso A, Adewale O, Unuofin J, Ekundayo B, Ntwasa M Heliyon. 2025; 11(1):e41605.

PMID: 39850441 PMC: 11754520. DOI: 10.1016/j.heliyon.2024.e41605.


Distinct roles of COMPASS subunits to Drosophila heart development.

Zhu J, van de Leemput J, Han Z Biol Open. 2024; 13(10).

PMID: 39417277 PMC: 11554255. DOI: 10.1242/bio.061736.


Current genetic models for studying congenital heart diseases: Advantages and disadvantages.

Shorbaji A, Pushparaj P, Bakhashab S, Al-Ghafari A, Al-Rasheed R, Mira L Bioinformation. 2024; 20(5):415-429.

PMID: 39132229 PMC: 11309114. DOI: 10.6026/973206300200415.


Arrhythmic Effects Evaluated on : The Case of Polypyrrole Nanoparticles.

Srinivasan S, Illera P, Kukhtar D, Benseny-Cases N, Ceron J, Alvarez J ACS Nano. 2023; 17(17):17273-17284.

PMID: 37624669 PMC: 10510705. DOI: 10.1021/acsnano.3c05245.


Evolution of the cardiac dyad.

Mackrill J Philos Trans R Soc Lond B Biol Sci. 2022; 377(1864):20210329.

PMID: 36189805 PMC: 9527923. DOI: 10.1098/rstb.2021.0329.


References
1.
Black B . Transcriptional pathways in second heart field development. Semin Cell Dev Biol. 2007; 18(1):67-76. PMC: 1855211. DOI: 10.1016/j.semcdb.2007.01.001. View

2.
Van Driest S, Vasile V, Ommen S, Will M, Tajik A, Gersh B . Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44(9):1903-10. DOI: 10.1016/j.jacc.2004.07.045. View

3.
Melkani G, Bodmer R, Ocorr K, Bernstein S . The UNC-45 chaperone is critical for establishing myosin-based myofibrillar organization and cardiac contractility in the Drosophila heart model. PLoS One. 2011; 6(7):e22579. PMC: 3143160. DOI: 10.1371/journal.pone.0022579. View

4.
Melkani G, Trujillo A, Ramos R, Bodmer R, Bernstein S, Ocorr K . Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. PLoS Genet. 2013; 9(12):e1004024. PMC: 3868535. DOI: 10.1371/journal.pgen.1004024. View

5.
Codd M, Sugrue D, Gersh B, Melton 3rd L . Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989; 80(3):564-72. DOI: 10.1161/01.cir.80.3.564. View